Lee Ji Hoon, Lee Kyung Seok, Kang Yong Koo, Yoo Kyung Ho, Shin Kye Jung, Kim Dong Chan, Kong Jae Yang, Lee Yeonhee, Lee Sook Ja, Kim Dong Jin
Medicinal Chemistry Research Center, Korea Institute of Science and Technology, PO Box 131, Cheongryang, Seoul 130-650, South Korea.
Bioorg Med Chem Lett. 2003 Dec 15;13(24):4399-403. doi: 10.1016/j.bmcl.2003.09.039.
The synthesis and antibacterial activity of novel 1beta-methylcarbapenems 1a-f bearing oxyiminopyrrolidinylamide moiety at C-5 position of pyrrolidine are described. Most compounds exhibited comparable antibacterial activity to meropenem against a wide range of Gram-positive and Gram-negative organisms including Pseudomonas aeruginosa isolates. Of these carbapenems, 1a showed potent and broad spectrum of antibacterial activity and similar stability to DHP-I to meropenem. Against clinical isolates of 40 Gram-negative bacterial species including MDR and ESBL-producing strains, the selected carbapenem 1a possessed excellent in vitro activity except for MDR P. aeruginosa, and was comparable in potency to meropenem.
描述了在吡咯烷的C-5位带有氧亚氨基吡咯烷基酰胺部分的新型1β-甲基碳青霉烯类化合物1a-f的合成及其抗菌活性。大多数化合物对包括铜绿假单胞菌分离株在内的多种革兰氏阳性和革兰氏阴性菌显示出与美罗培南相当的抗菌活性。在这些碳青霉烯类化合物中,1a显示出强效且广谱的抗菌活性,并且在对二氢吡喃-1(DHP-I)的稳定性方面与美罗培南相似。针对包括产生多重耐药性(MDR)和超广谱β-内酰胺酶(ESBL)的菌株在内的40种革兰氏阴性细菌临床分离株,除了MDR铜绿假单胞菌外,所选的碳青霉烯类化合物1a具有优异的体外活性,并且在效力上与美罗培南相当。